Guest guest Posted September 17, 2011 Report Share Posted September 17, 2011 News 4 new results for hepatitis c Bristol-Myers's Once-Daily Hepatitis C Drug Works in StudyBusinessWeeks experimental hepatitis C drug worked in combination with two established medicines to cure as many as 83 percent of patients, a study found. The trial tested three doses of the drug, called BMS-790052, with peginterferon and ribavirin, the standard ...See all stories on this topic » Telaprevir cuts hepatitis C treatmentUPI.com17 (UPI) -- A newly approved drug may cut the treatment of hepatitis C by some six months in about two-thirds of patients, US researchers say. Telaprevir, a drug approved by the US Food and Drug Administration in May, and a similar medication ...See all stories on this topic » Sanford Guide Introduces New Hepatitis GuideSacramento Bee"A revolution is occurring in the treatment of Hepatitis C virus infections, similar in magnitude to the rapid change in HIV therapy in the mid-1990s," said Jeb Sanford, managing editor. "A major difference between HIV therapy and Hepatitis C therapy ...See all stories on this topic » Teva to invest $7.5 mn in Cocrystal Discovery for novel antiviral therapeuticspharmabiz.comCurrently, CDI is using its unique technologies to develop oral, once-a-day, broad-spectrum antivirals for the treatment of Hepatitis C, influenza and rhinovirus (common cold). Under the terms of the agreement, Teva will initially invest $7.5 million ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.